Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Is Posting Gains, Do You Know Why?

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) has seen some recent movement in the market and its common shares closed trading at $78.47 yesterday. People are starting to take notice of BHVN as the common shares traded as high as $78.60 and as low as $75.74 in the prior market session.

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) average trading volume is 487.11K. However, in the prior market session Biohaven Pharmaceutical Holding Company Ltd. (BHVN) traded 476,392 shares. The 1st downside support level on BHVN is $78.03 and the 1st upside resistance level on BHVN is $83.34. BHVN 50day moving average is $70.10 and BHVN 200-day moving average is $63.23.

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) most recent performance has been shown by the recent movement in BHVN common shares. BHVN has performed 20.70% over the past month, BHVN has performed 22.53% over the past 90 days and BHVN has shown 73.49% over the past 365 days. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) has a 12 month range of $26.56 to $80.00. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) is trading 195.44% from its 12 month low and -1.91% from its 12 month high. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) is indicating a 19.57% short float indicating the quantity short in the float.

BHVN has 58.74M shares outstanding and 49.38M shares in the float. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) presently has a market cap of $4.73B and income of -609.30M. The EPS next quarter for BHVN is -2.89 and anticipated EPS next year is 25.00%. The market cap of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) at $4.73B represents how many People own shares of BHVN and is calculated off the last price ($78.47) of BHVN and the quantity of shares outstanding (58.74M) with Biohaven Pharmaceutical Holding Company Ltd. (BHVN).

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) has aggregate cash (mrq) of 261.06M, aggregate cash per share (mrq) of 4.37, aggregate debt of BHVN stands at 164.8M. Biohaven Pharmaceutical Holding Company Ltd. (BHVN) operating cash flow (ttm) is -497.11M, BHVN leveraged free cash flow (ttm) is -340.76M.

BHVN is trading 3.86% above (bullish) its SMA20, 16.27% above (bullish) its SMA50 and 37.62% above (bullish) its SMA200.

Related Articles

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Get in Touch

19,000FansLike
35,222FollowersFollow
22,458FollowersFollow

Latest Posts

Zebra (NASDAQ: ZBRA) And XMReality Inks Partnership Agreement

Zebra Technologies Corporation (NASDAQ: ZBRA) and XMReality publicized that the two have signed an agreement to work together and collaborate on ideas that offer...

Elanco (NYSE: ELAN) Launch Public Offering Of Common Stock

Elanco Animal Health Inc. (NYSE: ELAN) shares that it is planning to commence the public offering of 54,500,000 shares of common stock. It will...

Jacobs (NYSE: J) Partners with PA Consulting

Jacobs Engineering Group, Inc. (NYSE: J), a famous construction company announced that it will be collaborating with PA Consulting. The firm has purchased an...

Fuwei (NASDAQ: FFHL) Plans To Sell Dornier Production Line

Fuwei Films (Holdings) Co., Ltd. (NASDAQ: FFHL) recently declared that it will be closing its Dornier line of production as early as possible. Fuwei...

PPG Industries (NYSE: PPG) Announces Accquisition Of Ennis-Flint

PPG Industries, Inc. (NYSE: PPG) is planning to buy Ennis-Flint in a deal valued at nearly $1.15 billion. The decision to acquire Ennis-Flint will...